bone disease

#SCM16: Velphoro in ESRD

April 29, 2016 // 0 Comments

Dr. Stuart M. Sprague (SMS), from NorthShore University Health System University of Chicago Pritzker School of Medicine (Evanston, Illinois), discusses his abstracts for the National Kidney Foundation’s 2016 Spring Clinical Meetings (SCM16), [read more...]

Calciphylaxis – What Do We Know?

July 13, 2015 // 0 Comments

Calciphylaxis is a rare and devastating disease, affecting mostly patients with end-stage kidney disease, but also affecting patients with preserved kidney function. Due to the low prevalence of the disease, high quality evidence for the evaluation [read more...]

FGF-23 and Sudden Cardiac Death

February 17, 2015 // 0 Comments

Cardiovascular death and chronic kidney disease (CKD) are strongly linked, but there are few clear mechanisms that explain the reason for this association. Even in the early stages of CKD, cardiovascular morbidity is increased compared to the [read more...]

Ferric Citrate and Hyperphosphatemia

April 16, 2013 // 0 Comments

AJKD recently published an article from Dwyer et al on a dose-response and safety/tolerability trial of a novel phosphorous binder, ferric citrate, for dialysis patients. This trial demonstrated lower serum phosphorus levels with increasing dose. [read more...]